Резолюция Совета экспертов «Нормативный регламент и вопросы организации скрининга и прогнозирования преэклампсии в РФ»
Совет экспертов: В.Н. Серов, М.Д. Андреева, И.И. Баранов, Т.Е. Белокриницкая, Л.Д. Белоцерковцева, В.М. Гурьева, Т.Ю. Иванец, И.В. Игнатко, Н.Е. Кан, И.Ю. Коган, Р.В. Капустин, И.И. Кукарская, А.В. Михайлов, Н.М. Пасман, В.А. Петрухин, И.С. Савельева, О.Ф. Серова, И.Ф. Фаткуллин, З.С. Ходжаева.
Список литературы
- Brown M.A., Magee L.A., Kenny L.C., Karumanchi S.A., McCarthy F.P., Saito S., Hall D.R., Warren C.E., Adoyi G., Ishaku S.; International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertensive Disorders of Pregnancy: ISSHP Classification, Diagnosis, and Management Recommendations for International Practice. Hypertension. 2018; 72(1): 24-43. https://dx.doi.org/10.1161/HYPERTENSIONAHA.117.10803.
- Poon L.C., Shennan A., Hyett J.A., Kapur A., Hadar E. et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet. 2019; 145(Suppl 1): 1-33. https://dx.doi.org/10.1002/ijgo.12802.
- Основные показатели деятельности службы охраны здоровья матери и ребенка в Российской Федерации. 2018.
- Turbeville H.R., Sasser J.M. Preeclampsia beyond pregnancy: long-term consequences for mother and child. Am J Physiol Renal Physiol. 2020; 318(6): F1315-F1326. https://dx.doi.org/10.1152/ajprenal.00071.2020.
- Wu P., Haththotuwa R., Kwok C.S., Babu A., Kotronias R.A., Rushton C., Zaman A., Fryer A.A., Kadam U., Chew-Graham C.A., Mamas M.A. Preeclampsia and Future Cardiovascular Health: A Systematic Review and Meta-Analysis. Circ Cardiovasc Qual Outcomes. 2017; 10(2): e003497. https://dx.doi.org/10.1161/CIRCOUTCOMES.116.003497.
- Ходжаева З.С., Холин А.М., Вихляева Е.М. Ранняя и поздняя преэклампсия: парадигмы патобиологии и клиническая практика. Акушерство и гинекология. 2013; 10: 4-11.
- Khodzhaeva Z.S., Kogan Ye.A., Shmakov R.G., Klimenchenko N.I., Akatyeva A.S., Vavina O.V., Kholin A.M., Muminova K.T., Sukhikh G.T. Clinical and pathogenetic features of early- and late-onset pre-eclampsia. J Matern Fetal Neonatal Med. 2016; 29(18): 2980-6. https://dx.doi.org/10.3109/14767058.2015.1111332.
- Lisonkova S., Joseph K.S. Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. Am J Obstet Gynecol. 2013; 209(6): 544.e1-544.e12. https://dx.doi.org/10.1016/j.ajog.2013.08.019.
- Ташкина Е. А., Черных Е.Р., Пасман Н.М. Роль ангиогенных факторов и их взаимодействия с иммунной системой при неосложненной беременности и преэклампсии. Национальный конгресс «Дискуссионные вопросы современного акушерства» 15–17 июня 2017 г. Журнал акушерства и женских болезней. 2017: 79.
- Uzan J., Carbonnel M., Piconne O., Asmar R. Pre-eclampsia: Pathophysiology, diagnosis, and management. Vasc Health Risk Manag. 2011; 7(1): 467-74. https://dx.doi.org/10.2147/VHRM.S20181.
- Akolekar R., Syngelaki A., Poon L., Wright D., Nicolaides K.H. Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn Ther. 2013; 33(1): 8-15. doi: 10.1159/000341264.
- Ходжаева З.С., Холин А.М., Шувалова М.П., Иванец Т.Ю., Демура С.А., Галичкина И.В. Российская модель оценки эффективности теста на преэклампсию sFlt-1/PlGF. Акушерство и гинекология. 2019; 2: 52-8.
- Kenny L.C., Black M.A., Poston L., Taylor R., Myers J.E., Baker P.N., et al. Early pregnancy prediction of preeclampsia in nulliparous women, combining clinical risk and biomarkers: the Screening for Pregnancy Endpoints (SCOPE) international cohort study. Hypertens. 2014; 64(3): 644-52. https://dx.doi.org/10.1161/HYPERTENSIONAHA.
- O’Gorman N., Wright D., Syngelaki A., Akolekar R., Wright A., Poon L.C., et al. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation. Am J Obstet Gynecol. 2016; 214(1): 103.e1-103.e12. https://dx.doi.org/10.1016/j.ajog.2015.08.034.
- O’Gorman N., Wright D., Poon L.C., Rolnik D.L., Syngelaki A., Wright A., et al. Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks’ gestation. Ultrasound Obstet Gynecol. 2017; 49(6): 751-5. https://dx.doi.org/10.1002/uog.17399.
- Zhong Y., Zhu F., Ding Y. Serum screening in first trimester to predict pre-eclampsia, small for gestational age and preterm delivery: systematic review and meta-analysis. BMC Pregnancy Childbirth. 2015; 15:191. https://dx.doi.org/10.1186/s12884-015-0608-y.
- Zeisler H., Llurba E., Chantraine F., Vatish M., Staff A.C., Sennström M. et al. Predictive Value of the sFlt-1: PlGF Ratio in Women with Suspected Preeclampsia. N Engl J Med. 2016; 374(1): 13-22. https://dx.doi.org/10.1056/NEJMoa1414838.
- Hadker N., Garg S., Costanzo C., van der Helm W., Creeden J. Are there financial savings associated with supplementing current diagnostic practice for preeclampsia with a novel test? Learnings from a modeling analysis from a German payer perspective/ Hypertens Pregnancy, 2013; 32(2): 105-19. http://dx.doi.org/10.3109/10641955.2011.638958.
- Nielsen L.H., Sundtoft I., Vestgaard M.J., Persson L., Storgaard L., Salvig J.D. et al. Hypertension og præeklampsi. Indholdsfortegnelse. 2018.
- Rana S., Powe C.E., Salahuddin S., Verlohren S., Perschel F.H., Levine R.J., et al. Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected Preeclampsia. Circulation. 2012; 125(7): 911-9. https://dx.doi.org/10.1161/CIRCULATIONAHA.111.054361.
- Poon L.C., Galindo A., Surbek D., Chantraine F., Stepan H., Hyett J., Tan K.H., Verlohren S. From first-trimester screening to risk stratification of evolving pre-eclampsia in the second and third trimesters of pregnancy: a comprehensive approach. Ultrasound Obstet Gynecol. 2020; 55(1): 5-12. https://dx.doi.org/10.1002/uog.21869.
- Stepan H., Hund M., Dilba P., Sillman J., Schlembach D. Elecsys® and Kryptor immunoassays for the measurement of sFlt-1 and PlGF to aid preeclampsia diagnosis: are they comparable? Clin Chem Lab Med. 2019; 57(9): 1339-48. http://dx.doi.org/10.1515/cclm-2018-1228.
- Perdigao J.L, Chinthala S., Mueller A., Minhas R., Ramadan H., Nasim R. et al. Angiogenic Factor Estimation as a Warning Sign of Preeclampsia-Related Peripartum Morbidity Among Hospitalized Patients. Hypertension. 2019; 73(4): 868-77. https://dx.doi.org/10.1161/HYPERTENSIONAHA.118.12205.
- Dröge L.A., Höller A., Ehrlich L., Verlohren S., Henrich W., Perschel F.H. Diagnosis of preeclampsia and fetal growth restriction with the sFlt-1/PlGF ratio: Diagnostic accuracy of the automated immunoassay Kryptor®. Pregnancy Hypertens. 2017; 8: 31-6. https://dx.doi.org/10.1016/j.preghy.2017.02.005.
